Enlitic Lands $250K at St. Jude, Opens Door to Paediatric Hospital Market
Enlitic secures US$250,000 contract with St. Jude Children’s Research Hospital
Enlitic Inc (ASX: ENL) has announced a collaboration agreement with St. Jude Children’s Research Hospital for data migration services valued at US$250,000. The contract marks Enlitic’s first commercial engagement in the paediatric healthcare sector and creates a pathway for potential adoption of the company’s higher-margin SaaS platform, Ensight.
St. Jude is a globally recognised academic medical centre in Memphis, Tennessee, focused on advancing cures and improving outcomes for children with cancer and other life-threatening diseases. The institution operates one of the most advanced paediatric research and clinical data ecosystems globally, with strong emphasis on the integration and utilisation of imaging and genomic datasets to drive discovery and treatment innovation.
Under the agreement, Enlitic will deploy its core data migration technology at St. Jude. The migration services contract provides the catalyst for St. Jude to potentially access Enlitic’s AI-powered data management platform, Ensight, which delivers higher-margin SaaS-based offerings on top of the company’s core data migration initiatives.
When big ASX news breaks, our subscribers know first
March momentum — US$1.75 million in new contracts
The St. Jude contract forms part of broader commercial momentum for Enlitic in March 2026. Earlier this month, the company secured a US$1.5 million contract with Penn Medicine, taking the total value of new contracts awarded in March to US$1.75 million.
The combined March contract value demonstrates strengthening sales pipeline and growing demand for Enlitic’s data migration and AI-powered solutions across multiple healthcare institutions.
| Contract | Value | Announcement Date |
|---|---|---|
| Penn Medicine | US$1.5M | Early March 2026 |
| St. Jude Children’s Research Hospital | US$250,000 | 31 March 2026 |
The contracts demonstrate sustained commercial traction across multiple channels, including direct healthcare institution sales and OEM partnerships. This growing pipeline supports revenue visibility as Enlitic expands its market presence across North American healthcare institutions.
What is data migration in healthcare and why does it matter?
Healthcare data migration refers to the process of transferring medical imaging and clinical data from legacy systems to modern platforms. This involves moving large volumes of imaging data (such as MRI, CT scans, X-rays, and ultrasound images) whilst maintaining data integrity and accessibility.
Hospitals like St. Jude require these services due to fragmented data systems, interoperability challenges, and the need to extract value from imaging and genomic datasets. Legacy systems often lack the capability to support advanced analytics, AI-driven applications, or streamlined workflows required by modern research-intensive institutions.
For Enlitic, migration contracts serve as the entry point for the company’s higher-margin Ensight SaaS platform, creating a “land and expand” revenue model. Each new migration client represents a potential upsell opportunity for Ensight’s AI-powered data management capabilities.
Migration services act as a gateway to recurring SaaS revenue. Once deployed, healthcare providers can transition to Ensight’s enterprise imaging solution, which enables efficient access, management, and utilisation of large-scale medical imaging datasets.
The Ensight platform — Enlitic’s SaaS growth engine
Ensight is an enterprise SaaS imaging solution that enables healthcare providers to efficiently access, manage, and utilise large-scale medical imaging datasets. The platform supports streamlined workflows, improved interoperability, and the deployment of advanced analytics and AI-driven applications.
Key capabilities include data standardisation, protection, integration, and analysis, creating the foundation for a real-world evidence platform that can improve clinical workflows, increase efficiencies, and expand capacity. The commercial model layers higher-margin SaaS offerings on top of core migration services.
Ensight represents Enlitic’s pathway from one-time migration revenue to recurring, higher-margin SaaS income. St. Jude’s advanced data ecosystem, with its strong emphasis on imaging and genomic datasets, makes it an ideal candidate for platform adoption if the institution chooses to expand beyond migration services.
Strategic value of the St. Jude relationship
St. Jude’s profile as a world-leading paediatric research institution provides significant strategic value beyond the immediate contract revenue. The institution combines high-volume clinical care with world-leading research programmes and large-scale data-driven initiatives, positioning it at the forefront of paediatric oncology and precision medicine.
The relationship represents Enlitic’s first commercial engagement within the paediatric healthcare sector, providing strategic entry into a highly specialised and research-intensive segment of the global healthcare market. Establishing a relationship with an institution of St. Jude’s calibre provides strong third-party validation of Enlitic’s platform and creates potential to expand into adjacent paediatric and research-led health systems.
Michael Sistenich, CEO
“This strategic relationship is another strong validation of our technology and reflects the growing need among healthcare providers for solutions that extend beyond migration and standardisation, supporting a more effective approach to managing their data over time. We are proud to work with such a respected healthcare institution as St. Jude on an engagement which supports those priorities.”
Association with a globally recognised institution strengthens Enlitic’s brand and creates a reference case for similar research-intensive healthcare organisations. The credibility signal from securing St. Jude as a client could unlock opportunities across other paediatric and academic medical centres.
Growing sales channels — OEMs and direct partnerships
Enlitic’s commercial traction spans both direct healthcare institution sales and OEM channel partnerships. Management has noted that the company’s data migration technology continues to gain traction through OEM channels and directly with leading healthcare institutions in North America.
The dual-channel approach provides multiple avenues to deploy Ensight:
- Direct healthcare institution contracts (St. Jude, Penn Medicine)
- OEM partnerships with global healthcare technology providers
Diversified sales channels reduce customer concentration risk and increase scalability of commercial rollout. The growing number of migration contracts provides Enlitic with multiple pathways to integrate its AI-driven Ensight offering, which management describes as having exceptional functionality and considerable commercial appeal to customers.
The next major ASX story will hit our subscribers first
What to watch next
Near-term catalysts for Enlitic include potential Ensight adoption at St. Jude following completion of migration services, further contract announcements from the company’s strengthening sales pipeline, and progress updates on OEM channel expansion.
Migration contracts create pipeline visibility for future SaaS revenue conversion. The key metric investors should monitor is the conversion rate from migration contracts to Ensight SaaS subscriptions, as this indicates revenue quality improvement and the transition from one-time project revenue to recurring income streams.
Upcoming catalysts to monitor:
- Potential Ensight adoption at St. Jude following migration completion
- Additional migration contract announcements from the sales pipeline
- OEM channel expansion updates and partnership progress
The company’s ability to convert migration clients into Ensight subscribers will determine whether Enlitic can successfully execute its land-and-expand strategy and deliver the higher-margin revenue model management has outlined. With US$1.75 million in new contracts secured in March alone, the commercial momentum provides a foundation for this transition.
Want the Next Healthcare Breakthrough in Your Inbox?
Join 20,000+ investors receiving FREE breaking ASX healthcare news delivered within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at Big News Blast to get real-time alerts the moment market-moving announcements break across Tech, Healthcare, Finance, and beyond.